Genetracer products

Be a step ahead of cancer

logo-decoder    logo-spiral

Precision Molecular Biology tools; disruptive medical innovation for the prevention and treatment of disease

Genetracer Biotech: making customized medicine possible: Personalized, Predictive, Preventive and Participatory

Our products

Noninvasive blood test which delivers high quality circulating tumor cell (CTC) enrichment and circulating tumor DNA (ctDNA) using the advantages of the Liquid Biopsy and Next Generation Sequencing (NGS). The ability to detect and quantify tumor mutations has proven effective in tracking tumor dynamics in real time.

Spiral as a non-invasive test allows to decipher the genetic tumor fingerprint in asymptomatic people at risk and under medical prescription. Spiral is a personalized blood test which delivers the number of circulating tumor cells in the sample and analysed more than 3500 mutations associated to cancer, including hereditary cancer genes if it is needed.

Welcome to Genetracer Biotech

Precision medicine:

Incorporating genetic data to clinical information and therapies:


Logotipo Genetracer Biotech

Comprehensive technological solutions for precise, personalized medicine & biology

GGenetracer Biotech has the authorization of the counseling of health as authorized Center of Genetics (U.78) to market its first two major lines of business, products based on genotyping (SNPchip) and sequencing (NGS).

Our goal is to both scientific development and the marketing of multiple products in the field of nutritional Genomics, pharmacogenetics, cancer, (lung cancer and colon, breast cancer or the full panel of cancer), hereditary diseases, the exome and transcriptome analysis. 

These products can be self-developed based on a close collaboration with health workers through which it will be available or full (laboratories of clinical analyses, hospitals, offices, pharmacy, etc). 


Ver todos

“I have been working with Genetracer Biotech on a non-conventional sequencing project that has required a very active involvement of their technical staff.”

ico-pdf  Javier Ruiz Ederra. Neuroscience Department. BioDonostia, Health Research Institute

“Genetracer Biotech provided us customized services of gene expression in a large number of samples with high quality and personalized support.”

ico-pdf  Javier Meana. Pharmacology Department, University of the Basque Country

“I had an excellent experience working with Genetracer Biotech on Ampliseq Transcriptome Human Gene Panel with RNA samples from urine, formalin fixed paraffin embedded and laser capture microdissection.”

ico-pdf  Juanjo Lozano. Head of Bioinformatic CIBERehd Platform

“We have had the pleasure of working with Genetracer Biotech to perform a differential gene expression (DEG) analysis of RNA-seq with the Ampliseq Transcriptome Human Gene Panel.”

ico-pdf  Pau Sancho-Bru. Liver Fibrosis Lab. IDIBAPS

Genetracer Biotech in the news

310, 2017

Genetracer Biotech will participate in the Ion world tour 2017

On October 19th will be held the Ion world tour, in which Genetracer Biotech will act as a speaker talking about the liquid biopsy in cancer diagnosis: ctDNA vs FFPE [...]

2509, 2017

Genetracer Biotech in Brazil: Brazilian Congress of Clinical Pathology

Genetracer Biotech will be present from September 26 to 29 at the Brazilian Congress of Clinical Pathology, offering a session of the use of the liquid biopsy in the oncological [...]

1407, 2017

Genetracer obtains the Certificate of Excellence from the European Commission

Genetracer Biotech has obtained the certificate of excellence from the European Commission rating the project proposal as high quality in a highly competitive evaluation process.  


Genetracer Biotech awards

Instituto para la Excelencia Profesional: Recognition of professional work and commitment to Excellence

Cantábrico Excelente awards: Award in the category of Health Technology